| | | | | Merck & Co Inc said on Thursday it agreed to acquire privately held VelosBio for $2.75 billion in cash, in a move that will help it strengthen its cancer drug portfolio. | | |
| | | More than 6,000 people in Lanzhou, the capital of Gansu province in northwest China, have tested positive for a bacterial disease called brucellosis, the local government was cited as saying, in an outbreak caused by a leak at a vaccine plant over a year ago. | | |
| | | New coronavirus cases in Austria rose by a record-high 7,416 in the past 24 hours, newspaper Kronen Zeitung reported on Thursday, adding that 41 more deaths had been counted. | | |
| | | Parts of Denmark will face new, tougher lockdown measures after health authorities discovered a mutated coronavirus strain in minks and people in the country's northern regions. | | |
| | | Denmark, Europe's largest exporter of mink pelts, said it will cull millions of the animals bred for their fur after COVID-19 infections were transmitted to their keepers. | | |
| | | Prime Minister Erna Solberg told Norwegians to avoid travelling domestically and instead stay at home as much as possible, as part of a new round of recommendations and restrictions aimed at stopping the spread of the coronavirus. | | |
| | | India raced ahead with work on its coronavirus vaccine while Britain's AstraZeneca said its deliveries were running "a little bit late" as countries around the world sought to conquer the pandemic and rescue their economies. | | |
| | | Coronavirus infections rose by 10,128 in a day, data from Swiss health authorities showed on Thursday. | | |
| | | A summer dip in UK coronavirus infections has pushed back test results for AstraZenca's potential COVID-19 vaccine, leading the drugmaker to delay deliveries of shots to the UK government. | | |
| | | AstraZeneca will start discussing emergency approval of its experimental COVID-19 vaccine with U.S. regulators once it has good trial data from Britain, South Africa and Brazil, as it has no indication the watchdog would favour U.S. data. | | |
| | | Bangladesh signed a deal with the Serum Institute of India on Thursday to buy 30 million doses of a potential coronavirus vaccine being developed by British drugmaker AstraZeneca. | | |
|
| |
